Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02794662 · ClinicalTrials.gov registry record · NA
Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study
A NA study of Hypoxia and Infant, Newborn, Diseases, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02794662: Completed NA study of Hypoxia and Infant, Newborn, Diseases, sponsored by University of Alabama at Birmingham.
NCT02794662 is a NA study of Hypoxia and Infant, Newborn, Diseases that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 25 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02794662, a NA study of Hypoxia and Infant, Newborn, Diseases, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if, in preterm infants \< 37 weeks' gestation at birth receiving oxygen without ventilatory/CPAP support, oxygen environment (OE) compared with nasal cannula oxygen (NC), will decrease the number of episodes with oxygen saturations less than 85% of ≥10 seconds in a 48 hour cross over period on either intervention. This is a randomized cross-over pilot study with a 1:1 parallel allocation of infants to oxygen environment or nasal cannula oxygen using stratified permuted block design. Following a 24 hour period on the first intervention, infants will cross over to a 24 hour period on the second (alternative) intervention before crossing back to the first intervention for a further 24 hours and then back again to the second (alternative) intervention for a further 24 hours.
Conditions Studied
Interventions
- PROCEDURE Oxygen Environment
- PROCEDURE Nasal Cannula Oxygen
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02794662 record still lists
NCT02794662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Oxygen Environment is the first listed.
NCT02794662 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02794662 about?
NCT02794662 is a clinical study titled "Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study". The purpose of this study is to determine if, in preterm infants \< 37 weeks' gestation at birth receiving oxygen without ventilatory/CPAP support, oxygen environment (OE) compared with nasal cannula oxygen (NC), will decrease the number of episodes with oxygen saturations less than 85% of ≥10 secon...
What is the current status of trial NCT02794662?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-04. Estimated completion is 2016-09.
What conditions does trial NCT02794662 study?
This clinical trial studies the following conditions: Hypoxia, Infant, Newborn, Diseases.
What interventions are being tested in trial NCT02794662?
The interventions under investigation include: Oxygen Environment (PROCEDURE), Nasal Cannula Oxygen (PROCEDURE).
Who is sponsoring clinical trial NCT02794662?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02794662 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02794662's enrollment target sits among peer trials
25 23rd of 39 higher than 17 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Structural Modification In Supraglottic Airway Device
RECRUITING · NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia